Cigna and Humana in deal talks to create US health insurance giant - Financial Times
| HUM Stock | SEK 36.50 0.20 0.55% |
Slightly above 52% of Humana AB's investor base is interested to short. The analysis of current outlook of investing in Humana AB suggests that many traders are impartial regarding Humana AB's prospects. Humana AB's investing sentiment can be driven by a variety of factors including economic data, Humana AB's earnings reports, geopolitical events, and overall market trends.
Humana |
Cigna and Humana in deal talks to create US health insurance giant Financial Times
Read at news.google.com
 |
Humana AB Fundamental Analysis
We analyze Humana AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humana AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humana AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Humana AB is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Humana AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Humana AB stock to make a market-neutral strategy. Peer analysis of Humana AB could also be used in its relative valuation, which is a method of valuing Humana AB by comparing valuation metrics with similar companies.
Peers
Humana AB Related Equities
| BMAX | Byggmax Group | 1.69 | ||||
| AMBEA | Ambea AB | 1.49 | ||||
| ACAD | AcadeMedia | 1.33 | ||||
| INWI | Inwido AB | 0.77 | ||||
| ATT | Attendo AB | 0.31 |
Additional Tools for Humana Stock Analysis
When running Humana AB's price analysis, check to measure Humana AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana AB is operating at the current time. Most of Humana AB's value examination focuses on studying past and present price action to predict the probability of Humana AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humana AB's price. Additionally, you may evaluate how the addition of Humana AB to your portfolios can decrease your overall portfolio volatility.